+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 18Years - 90Years
All Genders
ID06594783

Comparing Carvedilol With or Without Endoscopic Variceal Ligation to Prevent First Esophageal Variceal Bleeding in Cirrhosis Patients Not Responding to Carvedilol

Led by Taipei Veterans General Hospital, Taiwan · Updated on 2025-02-11

80

Participants Needed

1

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

This research aims to compare the effectiveness of carvedilol combined with endoscopic variceal ligation EVL versus carvedilol alone in preventing the first esophageal variceal bleeding in patients with cirrhosis who do not respond to carvedilol. The study also seeks to learn about the safety of combining carvedilol with EVL and to explore differences in other gastrointestinal bleeding, liver complications, overall survival, adverse events, and tolerability between the two approaches. Participants will be randomly assigned to one of two groups one group will take carvedilol daily starting at 6.25 mg and increasing to 12.5 mg if tolerated, along with EVL procedures every 3 to 4 weeks until varices are eradicated, followed by regular endoscopic checkups the other group will take carvedilol alone with the same dosing schedule. The study is open-label and includes regular clinical visits and follow-ups according to protocol. During the study, participants will visit the clinic every 2 to 3 months for checkups and tests. They will keep a diary to record vital signs such as systolic and diastolic blood pressure and heart rate, as well as any symptoms. The main outcome measured is the occurrence of esophageal variceal bleeding over three years. Secondary outcomes include other upper gastrointestinal bleeding, liver decompensation events, overall survival, and adverse events. The study is sponsored by Taipei Veterans General Hospital, Taiwan.

CONDITIONS

Brief Title

Carvedilol Plus EVL or Not for the Primary Prevention of Esophageal Variceal Bleeding in Carvedilol Non-responders

Research Team

T

Tsung-Chieh Yang, MD

M

Ming-Chih Hou, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here